Jiehai Yu

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0001-7554-0018

发表论文 31 篇 · 总被引 624 次 · h-index 10

代表论文

• Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer (2024 · Nature Communications · 被引 53)
• Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study (2024 · The Lancet Oncology · 被引 50)
• Risks of Organ Preservation in Rectal Cancer: Data From Two International Registries on Rectal Cancer (2024 · Journal of Clinical Oncology · 被引 34)
• Locally advanced rectal cancer with dMMR/MSI-H may be excused from surgery after neoadjuvant anti-PD-1 monotherapy: a multiple-center, cohort study (2023 · Frontiers in Immunology · 被引 28)
• Long-Term Outcomes of dMMR/MSI-H Rectal Cancer Treated With Anti–PD-1–Based Immunotherapy as Curative-Intent Treatment (2024 · Journal of the National Comprehensive Cancer Network · 被引 26)
• Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients (2023 · European Journal of Cancer · 被引 25)